https://www.selleckchem.com/products/AZD0530.html
By contrast, roles of EP1 and the exact pathological mechanisms have not been completely clarified. The studies concerning EP receptors in gynecological cancers highlight the potential advantage of combining COX enzyme inhibitors with EP receptor antagonists as therapeutic agents in gynecological cancers. CONCLUSION EPs represent promising anti-inflammation biomarkers for gynecological cancer and may be novel treatment targets in the near future.PURPOSE To prospectively compare the diagnostic accuracy of radial breast ultrasound (r-US)
Like
Comment
Share
